It’s ‘going to be tough’: UC Berkeley struggles to find sympathetic court in CRISPR patent appeal
The University of California, which has been losing the fight over U.S. patents on the genome-editing technology CRISPR-Cas9, did not pull any rabbits out of a hat during oral arguments…
WASHINGTON — The University of California, which has been losing the fight over U.S. patents on the revolutionary genome-editing technology CRISPR-Cas9, did not pull any rabbits out of a hat during oral arguments Monday in its appeal of the case.
The university clearly failed to win over at least one of the three judges and, at best, did not lose too much ground with a second (while the third asked almost no questions and so did not tip his hand).
“UC came into this argument from a tough spot, and I doubt that oral arguments from either side moved the needle much,” said patent attorney Michael Stramiello of Paul Hastings, who attended the arguments at the U.S. Court of Appeals for the Federal Circuit, where attorneys for the University
